Related Experiment Videos
Characterization of a novel metabolic strategy used by drug-resistant tumor cells
Mary-Ellen Harper1, Andreas Antoniou, Elizabeth Villalobos-Menuey
1Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Abstract:
Acquired or inherent drug resistance is the major problem in achieving successful cancer treatment. However, the mechanism(s) of pleiotropic drug resistance remains obscure. We have identified and characterized a cellular metabolic strategy that differentiates drug-resistant cells from drug-sensitive cells. This strategy may serve to protect drug-resistant cells from damage caused by chemotherapeutic agents and radiation. We show that drug-resistant cells have low mitochondrial membrane potential, use nonglucose carbon sources (fatty acids) for mitochondrial oxygen consumption when glucose becomes limited, and are protected from exogenous stress such as radiation. In addition, drug-resistant cells express high levels of mitochondrial uncoupling protein 2 (UCP2). The discovery of this metabolic strategy potentially facilitates the design of novel therapeutic approaches to drug resistance.
Insights
Drug-resistant cancer cells exhibit a distinct metabolic strategy, utilizing fatty acids for energy and expressing high levels of mitochondrial uncoupling protein 2 (UCP2). This cellular adaptation protects them from chemotherapy and radiation, offering new therapeutic targets.
Area of Science:
- Biochemistry
- Cancer Biology
- Cellular Metabolism
Background:
- Drug resistance is a significant obstacle in cancer treatment.
- The underlying mechanisms of pleiotropic drug resistance are not fully understood.
- Cellular metabolic reprogramming is increasingly recognized as a key factor in cancer progression and treatment resistance.
Purpose of the Study:
- To identify and characterize the cellular metabolic strategies employed by drug-resistant cancer cells.
- To elucidate the mechanisms by which drug resistance protects cells from chemotherapeutic agents and radiation.
- To explore the potential of targeting metabolic pathways for overcoming drug resistance.
Main Methods:
- Comparative analysis of metabolic profiles between drug-sensitive and drug-resistant cancer cells.
- Measurement of mitochondrial membrane potential and oxygen consumption rates.
- Assessment of cellular responses to exogenous stress, including radiation.
- Quantification of mitochondrial uncoupling protein 2 (UCP2) expression levels.
Main Results:
- Drug-resistant cells exhibit lower mitochondrial membrane potential compared to sensitive cells.
- Resistant cells preferentially utilize non-glucose carbon sources, such as fatty acids, for mitochondrial respiration under limited glucose conditions.
- Drug-resistant cells demonstrate enhanced protection against exogenous stressors like radiation.
- High expression levels of mitochondrial uncoupling protein 2 (UCP2) were observed in drug-resistant cells.
Conclusions:
- A specific cellular metabolic strategy, characterized by altered mitochondrial function and UCP2 upregulation, differentiates drug-resistant from drug-sensitive cancer cells.
- This metabolic adaptation confers resistance to chemotherapeutic agents and radiation by protecting cells from damage.
- The identified metabolic vulnerabilities in drug-resistant cells present potential targets for novel therapeutic interventions aimed at overcoming cancer drug resistance.